Sputnik V has demonstrated 97.8% efficacy against COVID-19 in UAE

Sputnik V has demonstrated 97.8% efficacy against COVID-19 in UAE

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the data of UAE’s Ministry of Health on the Russian Sputnik V coronavirus vaccine confirming its safety and high efficacy during the vaccination campaign.

Efficacy among more than 81,000 subjects who had received both components of Sputnik V was 97.8%. Analysis is based on the data collected by June 8, 2021.

The Russian vaccine was also fully (100%) effective against severe cases of COVID.

Vaccination data indicates high safety of Sputnik V:

  • No severe adverse events associated with vaccination;
  • No cases of hospitalization after vaccination:
  • No deaths related to the vaccination;
  • No cerebral vein thrombosis (CVT) cases after vaccination;
  • No cases of myocarditis reported.

Sputnik V was registered in UAE in January 2021 under the emergency use authorization procedure.

Kirill Dmitriev
Kirill Dmitriev
CEO of the Russian Direct Investment Fund
Sputnik V complies with the highest healthcare standards while demonstrating safety and efficacy during the vaccination in UAE. Sputnik V is one of the best COVID vaccines in the world as confirmed by data from Argentina, Serbia, San-Marino, Bahrain, Hungary, Mexico and other countries. Administering the Russian vaccine helps create durable immunity among the population and provides for lifting the restrictions and returning to normal life.

Search engine for pharmaceutical industry resources

Type in a search phrase such as - gmp and get the search result

Don’t miss your daily PharmaProm.Ru news.
SUBSCRIBE free here